Alpelisib improves the symptoms of infant PROS patients (IMAGE)
Caption
MRI shows the reduction in vascular malformations and leg size induced by alpelisib treatment.
Credit
© 2022 Morin et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20212148
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms.
License
CC BY-NC-SA